Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
30.8%
% of BBP's 55 holdings also in SBIO
18.6%
% of SBIO's 87 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
SPRINGWORKS THERAPEUTICS, INC. | 2.6% | 2.3% | 2.3% |
|
AXSOME THERAPEUTICS, INC. | 2.0% | 2.3% | 2.0% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED ADR | 1.9% | 1.9% | 1.9% |
|
ACADIA PHARMACEUTICALS INC | 1.5% | 1.8% | 1.5% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.8% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to SBIO
|
LEXICON PHARMACEUTICALS, INC. | 3.4% |
|
TARSUS PHARMACEUTICALS, INC. | 2.7% |
|
ADMA BIOLOGICS, INC. | 2.5% |
|
SAREPTA THERAPEUTICS INC | 2.4% |
|
CRISPR THERAPEUTICS AG | 2.4% |
|
ASCENDIS PHARMA A/S | 2.3% |
|
APELLIS PHARMACEUTICALS, INC. | 2.2% |
|
AMYLYX PHARMACEUTICALS, INC. | 2.2% |
|
ULTRAGENYX PHARMACEUTICAL IN | 2.1% |
|
LIGAND PHARMACEUTICALS-CL B | 2.1% |
BBP Underweight Relative to SBIO
|
VIKING THERAPEUTICS, INC. | -5.3% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | -4.8% |
|
VAXCYTE, INC. | -4.6% |
|
REVOLUTION MEDICINES, INC. | -3.1% |
 |
ALKERMES PLC | -2.8% |
|
ARCELLX, INC. | -2.3% |
|
CRINETICS PHARMACEUTICALS INC | -2.1% |
|
XENON PHARMACEUTICALS INC. | -2.0% |
|
IDEAYA BIOSCIENCES, INC. | -2.0% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -1.9% |